-
Deine Einschätzung
Was spricht für und gegen Advanced Proteome Therapeutics in den nächsten Jahren?
Pro
Kontra
Rendite von Advanced Proteome Therapeutics im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Larimar Therapeutics Inc. | 16,98 % | 12,77 % | 7,43 % | 9,66 % | -4,22 % | 11,97 % | -65,81 % |
| Northwest Biotherapeutics Inc. | - | -5,88 % | -0,62 % | -13,04 % | -22,33 % | -68,63 % | -86,09 % |
| Celldex Therapeutics | -0,12 % | 1,73 % | 32,99 % | 77,67 % | 52,64 % | 4,29 % | 30,05 % |
News
Artificial Intelligence (AI) Stocks Have Crushed the Broader Market in 2026. Here Are 2 Top Stocks to Buy Before They Soar Higher This Earnings Season and Beyond
Artificial intelligence (AI) continues to be the driving force behind the broader stock market's gains in 2026, even though the sector has experienced volatility this year for various reasons.
The
Coca-Cola Is Crushing the S&P 500 and Nasdaq-100. But There's an Even Better Reason to Buy the Stock in July.
As of market close on July 8, the Nasdaq-100, which consists of the 100 largest non-financial companies listed on the Nasdaq stock exchange, is up a rip-roaring 16% in 2026, while the S&P 500 is up
Advanced Micro Devices vs. Texas Instruments: Which Technology Stock Is a Better Buy in 2026?
Advanced Micro Devices (NASDAQ:AMD) and Texas Instruments (NASDAQ:TXN) represent two different ways to play the semiconductor market. Choosing between them depends on whether you prefer high-growth


